本页面由Tiger Trade Technology Pte. Ltd.提供服务

梯瓦制药

31.26
-0.3500-1.11%
盘后31.23-0.0300-0.10%19:37 EDT
成交量:468.22万
成交额:1.47亿
市值:364.18亿
市盈率:25.83
高:31.75
开:31.72
低:31.21
收:31.61
52周最高:37.35
52周最低:13.04
股本:11.65亿
流通股本:11.42亿
量比:1.27
换手率:0.41%
股息:- -
股息率:- -
每股收益(TTM):1.21
每股收益(LYR):1.21
净资产收益率:20.79%
总资产收益率:6.17%
市净率:4.60
市盈率(LYR):25.83

数据加载中...

2020/08/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/13

SEC问询函

CORRESP [Cover] - Correspondence
2020/08/06

重要事件披露

8-K - Current report
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/06/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/09

重要事件披露

8-K - Current report
2020/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/02/21

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/05

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超过5%披露

Statement of acquisition of beneficial ownership by individuals